Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

EVGN holding history

Evogene Ltd. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EVGN overviewAll 13F holders of EVGNFull Q2 2026 holdings

Shares (Q2 2026)
10,790
Value
$4.74K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EVGN by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,790$4.74K<0.1%+4,438+69.9%AddedHolders
Q1 20266,352$4.89K<0.1%+5,155+430.7%AddedHolders
Q4 20251,197$1.32K<0.1%−4−0.3%ReducedHolders
Q3 20251,201$1.37K<0.1%−5,528−82.2%ReducedHolders
Q2 20256,729$8.61K<0.1%−12,016−64.1%ReducedHolders
Q1 202518,745$23.4K<0.1%−3,267−14.8%ReducedHolders
Q4 202422,012$41.2K<0.1%+13,411+155.9%AddedHolders
Q3 20248,601$26.4K<0.1%+2,001+30.3%AddedConverted for a 1-for-10 splitHolders
Q2 202466,005$42.9K<0.1%+3,510+5.6%AddedHolders
Q1 202462,495$46.9K<0.1%+6,490+11.6%AddedHolders
Q4 202356,005$47.0K<0.1%+20,000+55.5%AddedHolders
Q3 202336,005$21.1K<0.1%+6,982+24.1%AddedHolders
Q2 202329,023$31.1K<0.1%+8,018+38.2%AddedHolders
Q1 202321,005$13.2K<0.1%−38−0.2%ReducedHolders
Q4 202221,043$14.7K<0.1%+3,500+20.0%AddedHolders
Q3 202217,543$15.0K<0.1%+3,038+20.9%AddedHolders
Q2 202214,505$11.0K<0.1%−21,260−59.4%ReducedHolders
Q1 202235,765$47.0K<0.1%−18,767−34.4%ReducedHolders
Q4 202154,532$90.0K<0.1%+40,051+276.6%AddedHolders
Q3 202114,481$38.0K<0.1%−20,777−58.9%ReducedHolders
Q2 202135,258$121.0K<0.1%+7,589+27.4%AddedHolders
Q1 202127,669$139.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.